Laurie B. Keating
2014 - Alnylam Pharmaceuticals
In 2014, Laurie B. Keating earned a total compensation of $5.3M as Senior Vice President, General Counsel and Secretary at Alnylam Pharmaceuticals.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $57,000 |
| Option Awards | $5,035,500 |
| Salary | $110,769 |
| Other | $1,733 |
| Total | $5,305,002 |
Keating received $5M in option awards, accounting for 95% of the total pay in 2014.
Keating also received $100K in bonus, $57K in non-equity incentive plan, $110.8K in salary and $1.7K in other compensation.
Rankings
In 2014, Laurie B. Keating's compensation ranked 1,440th out of 13,032 executives tracked by ExecPay. In other words, Keating earned more than 89.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,440 out of 13,032 | 89th |
Division Manufacturing | 518 out of 4,965 | 90th |
Major group Chemicals And Allied Products | 160 out of 1,690 | 91st |
Industry group Drugs | 125 out of 1,369 | 91st |
Industry Pharmaceutical Preparations | 110 out of 1,042 | 89th |
Source: SEC filing on March 10, 2015.
Keating's colleagues
We found four more compensation records of executives who worked with Laurie B. Keating at Alnylam Pharmaceuticals in 2014.
2014
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2014
Barry Greene
Alnylam Pharmaceuticals
Chief Operating Officer
2014
Akshay Vaishnaw
Alnylam Pharmaceuticals
Chief Medical Officer
2014
Michael Mason
Alnylam Pharmaceuticals